retatrutide commercial name brand Retatrutide, a new weight loss drug not available on the market yet, is Retatrutide for weight loss: Study

PMID 1319994

It contains the ingredients from all the other injections plus more

We also need to look at people who may not need weight reduction but are at high risk for cardiometabolic, renal hepatic and central nervous system disease

This guide walks through the full TRIUMPH program, the TRIUMPH-4 dataset, the 2026 readouts still to come, how retatrutide stacks up against tirzepatide and semaglutide on published trial data, and what the regulatory picture realistically looks like from here

On the basis of these findings, a clinical study program was started to investigate the efficacy and safety of tirzepatide in the treatment of obesity and obesity management